VEGFC and breast cancer: Moreover, CCL21/CCR7 chemokine axis has the ability to promote lymphatic endothelial cells proliferation, migration, as well as tube formation in vitro, and this axis also regulates the expression of lymphangiogenic factor VEGF-C by breast cancer cells.